nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—GABRR3—peripheral nervous system—Parkinson's disease	0.0287	0.0628	CbGeAlD
Quazepam—GABRR2—peripheral nervous system—Parkinson's disease	0.0249	0.0545	CbGeAlD
Quazepam—GABRR1—peripheral nervous system—Parkinson's disease	0.0239	0.0524	CbGeAlD
Quazepam—GABRR3—nerve—Parkinson's disease	0.0224	0.049	CbGeAlD
Quazepam—GABRR2—nerve—Parkinson's disease	0.0194	0.0425	CbGeAlD
Quazepam—GABRR1—nerve—Parkinson's disease	0.0187	0.0409	CbGeAlD
Quazepam—GABRA2—hindbrain—Parkinson's disease	0.00782	0.0171	CbGeAlD
Quazepam—GABRR1—forebrain—Parkinson's disease	0.00773	0.0169	CbGeAlD
Quazepam—GABRA1—hindbrain—Parkinson's disease	0.00755	0.0166	CbGeAlD
Quazepam—GABRD—forebrain—Parkinson's disease	0.00672	0.0147	CbGeAlD
Quazepam—GABRG1—forebrain—Parkinson's disease	0.00647	0.0142	CbGeAlD
Quazepam—GABRA5—forebrain—Parkinson's disease	0.00624	0.0137	CbGeAlD
Quazepam—GABRR3—head—Parkinson's disease	0.0053	0.0116	CbGeAlD
Quazepam—GABRR3—nervous system—Parkinson's disease	0.00503	0.011	CbGeAlD
Quazepam—GABRD—medulla oblongata—Parkinson's disease	0.00485	0.0106	CbGeAlD
Quazepam—GABRG2—forebrain—Parkinson's disease	0.00473	0.0104	CbGeAlD
Quazepam—GABRG1—medulla oblongata—Parkinson's disease	0.00467	0.0102	CbGeAlD
Quazepam—GABRG3—head—Parkinson's disease	0.00464	0.0102	CbGeAlD
Quazepam—GABRR2—head—Parkinson's disease	0.0046	0.0101	CbGeAlD
Quazepam—GABRB1—medulla oblongata—Parkinson's disease	0.00453	0.00992	CbGeAlD
Quazepam—GABRA2—brainstem—Parkinson's disease	0.00448	0.00982	CbGeAlD
Quazepam—GABRD—midbrain—Parkinson's disease	0.00444	0.00972	CbGeAlD
Quazepam—GABRR1—head—Parkinson's disease	0.00443	0.0097	CbGeAlD
Quazepam—GABRG3—nervous system—Parkinson's disease	0.0044	0.00965	CbGeAlD
Quazepam—GABRR2—nervous system—Parkinson's disease	0.00436	0.00955	CbGeAlD
Quazepam—GABRA1—brainstem—Parkinson's disease	0.00433	0.00949	CbGeAlD
Quazepam—GABRA2—forebrain—Parkinson's disease	0.00432	0.00947	CbGeAlD
Quazepam—GABRG1—midbrain—Parkinson's disease	0.00427	0.00935	CbGeAlD
Quazepam—GABRG3—central nervous system—Parkinson's disease	0.00424	0.00929	CbGeAlD
Quazepam—GABRR1—nervous system—Parkinson's disease	0.0042	0.00919	CbGeAlD
Quazepam—GABRA1—forebrain—Parkinson's disease	0.00418	0.00916	CbGeAlD
Quazepam—GABRG1—spinal cord—Parkinson's disease	0.00417	0.00913	CbGeAlD
Quazepam—GABRB1—midbrain—Parkinson's disease	0.00414	0.00907	CbGeAlD
Quazepam—GABRR2—cerebellum—Parkinson's disease	0.0041	0.00899	CbGeAlD
Quazepam—GABRR1—central nervous system—Parkinson's disease	0.00404	0.00885	CbGeAlD
Quazepam—GABRB1—spinal cord—Parkinson's disease	0.00404	0.00885	CbGeAlD
Quazepam—GABRD—head—Parkinson's disease	0.00385	0.00843	CbGeAlD
Quazepam—GABRG1—head—Parkinson's disease	0.0037	0.00811	CbGeAlD
Quazepam—GABRD—nervous system—Parkinson's disease	0.00365	0.00799	CbGeAlD
Quazepam—GABRB3—forebrain—Parkinson's disease	0.00363	0.00796	CbGeAlD
Quazepam—GABRB1—head—Parkinson's disease	0.00359	0.00787	CbGeAlD
Quazepam—GABRA5—head—Parkinson's disease	0.00357	0.00782	CbGeAlD
Quazepam—GABRD—central nervous system—Parkinson's disease	0.00351	0.00769	CbGeAlD
Quazepam—GABRG1—nervous system—Parkinson's disease	0.00351	0.00769	CbGeAlD
Quazepam—GABRD—cerebellum—Parkinson's disease	0.00343	0.00752	CbGeAlD
Quazepam—GABRG2—medulla oblongata—Parkinson's disease	0.00342	0.00749	CbGeAlD
Quazepam—GABRB1—nervous system—Parkinson's disease	0.0034	0.00746	CbGeAlD
Quazepam—GABRA5—nervous system—Parkinson's disease	0.00339	0.00742	CbGeAlD
Quazepam—GABRG1—central nervous system—Parkinson's disease	0.00338	0.0074	CbGeAlD
Quazepam—GABRG3—brain—Parkinson's disease	0.00337	0.00737	CbGeAlD
Quazepam—GABRA3—head—Parkinson's disease	0.00332	0.00728	CbGeAlD
Quazepam—GABRG1—cerebellum—Parkinson's disease	0.0033	0.00724	CbGeAlD
Quazepam—GABRB1—central nervous system—Parkinson's disease	0.00328	0.00718	CbGeAlD
Quazepam—GABRA5—central nervous system—Parkinson's disease	0.00326	0.00714	CbGeAlD
Quazepam—GABRP—head—Parkinson's disease	0.00322	0.00705	CbGeAlD
Quazepam—GABRR1—brain—Parkinson's disease	0.00321	0.00703	CbGeAlD
Quazepam—GABRB1—cerebellum—Parkinson's disease	0.0032	0.00702	CbGeAlD
Quazepam—GABRA3—nervous system—Parkinson's disease	0.00315	0.0069	CbGeAlD
Quazepam—GABRG2—midbrain—Parkinson's disease	0.00312	0.00685	CbGeAlD
Quazepam—GABRG2—spinal cord—Parkinson's disease	0.00305	0.00668	CbGeAlD
Quazepam—GABRA3—central nervous system—Parkinson's disease	0.00303	0.00665	CbGeAlD
Quazepam—GABRA1—medulla oblongata—Parkinson's disease	0.00302	0.00661	CbGeAlD
Quazepam—GABRD—brain—Parkinson's disease	0.00279	0.00611	CbGeAlD
Quazepam—GABRA1—midbrain—Parkinson's disease	0.00276	0.00605	CbGeAlD
Quazepam—GABRG2—head—Parkinson's disease	0.00271	0.00594	CbGeAlD
Quazepam—GABRA1—spinal cord—Parkinson's disease	0.00269	0.0059	CbGeAlD
Quazepam—GABRG1—brain—Parkinson's disease	0.00268	0.00588	CbGeAlD
Quazepam—GABRB3—medulla oblongata—Parkinson's disease	0.00263	0.00575	CbGeAlD
Quazepam—GABRB1—brain—Parkinson's disease	0.0026	0.0057	CbGeAlD
Quazepam—GABRA5—brain—Parkinson's disease	0.00259	0.00567	CbGeAlD
Quazepam—GABRG2—nervous system—Parkinson's disease	0.00257	0.00563	CbGeAlD
Quazepam—GABRA2—head—Parkinson's disease	0.00248	0.00542	CbGeAlD
Quazepam—GABRG2—central nervous system—Parkinson's disease	0.00247	0.00542	CbGeAlD
Quazepam—GABRE—head—Parkinson's disease	0.00245	0.00538	CbGeAlD
Quazepam—GABRG2—cerebellum—Parkinson's disease	0.00242	0.0053	CbGeAlD
Quazepam—GABRA3—brain—Parkinson's disease	0.00241	0.00528	CbGeAlD
Quazepam—GABRB3—midbrain—Parkinson's disease	0.0024	0.00526	CbGeAlD
Quazepam—GABRA1—head—Parkinson's disease	0.00239	0.00524	CbGeAlD
Quazepam—GABRA2—nervous system—Parkinson's disease	0.00235	0.00514	CbGeAlD
Quazepam—GABRB3—spinal cord—Parkinson's disease	0.00234	0.00513	CbGeAlD
Quazepam—GABRE—nervous system—Parkinson's disease	0.00233	0.0051	CbGeAlD
Quazepam—GABRA1—nervous system—Parkinson's disease	0.00227	0.00497	CbGeAlD
Quazepam—GABRA2—central nervous system—Parkinson's disease	0.00226	0.00495	CbGeAlD
Quazepam—GABRE—central nervous system—Parkinson's disease	0.00224	0.00491	CbGeAlD
Quazepam—GABRA2—cerebellum—Parkinson's disease	0.00221	0.00484	CbGeAlD
Quazepam—GABRA1—central nervous system—Parkinson's disease	0.00218	0.00478	CbGeAlD
Quazepam—GABRA1—cerebellum—Parkinson's disease	0.00213	0.00468	CbGeAlD
Quazepam—GABRB3—head—Parkinson's disease	0.00208	0.00456	CbGeAlD
Quazepam—CYP2C9—cardiovascular system—Parkinson's disease	0.00206	0.00452	CbGeAlD
Quazepam—GABRB3—nervous system—Parkinson's disease	0.00197	0.00432	CbGeAlD
Quazepam—GABRG2—brain—Parkinson's disease	0.00196	0.0043	CbGeAlD
Quazepam—GABRB3—central nervous system—Parkinson's disease	0.0019	0.00416	CbGeAlD
Quazepam—GABRB3—cerebellum—Parkinson's disease	0.00186	0.00407	CbGeAlD
Quazepam—GABRA2—brain—Parkinson's disease	0.00179	0.00393	CbGeAlD
Quazepam—GABRE—brain—Parkinson's disease	0.00178	0.0039	CbGeAlD
Quazepam—GABRA1—brain—Parkinson's disease	0.00173	0.0038	CbGeAlD
Quazepam—GABRB3—brain—Parkinson's disease	0.00151	0.0033	CbGeAlD
Quazepam—Clonazepam—CYP2E1—Parkinson's disease	0.00136	0.223	CrCbGaD
Quazepam—Flunitrazepam—CYP2E1—Parkinson's disease	0.00109	0.179	CrCbGaD
Quazepam—CYP3A4—nervous system—Parkinson's disease	0.00101	0.00221	CbGeAlD
Quazepam—CYP3A4—central nervous system—Parkinson's disease	0.000972	0.00213	CbGeAlD
Quazepam—Flurazepam—CYP2E1—Parkinson's disease	0.000874	0.144	CrCbGaD
Quazepam—Midazolam—CYP2E1—Parkinson's disease	0.00081	0.134	CrCbGaD
Quazepam—Diazepam—CYP2E1—Parkinson's disease	0.000694	0.114	CrCbGaD
Quazepam—Flurazepam—ABCB1—Parkinson's disease	0.000458	0.0755	CrCbGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000433	0.000806	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—COMT—Parkinson's disease	0.000433	0.000806	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—DLG4—Parkinson's disease	0.000433	0.000805	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000432	0.000804	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—MAOA—Parkinson's disease	0.00043	0.0008	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—COMT—Parkinson's disease	0.000427	0.000794	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—DLG4—Parkinson's disease	0.000425	0.00079	CbGpPWpGaD
Quazepam—Midazolam—ABCB1—Parkinson's disease	0.000425	0.07	CrCbGaD
Quazepam—GABRB1—Neuronal System—MAOA—Parkinson's disease	0.000424	0.000788	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	0.000423	0.000787	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000418	0.000777	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—DLG4—Parkinson's disease	0.000418	0.000777	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	0.000417	0.000775	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	0.000415	0.000772	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—DLG4—Parkinson's disease	0.000415	0.000772	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000414	0.00077	CbGpPWpGaD
Quazepam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000412	0.000767	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000412	0.000766	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	0.000409	0.000761	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	0.000408	0.000759	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000407	0.000758	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000407	0.000756	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000405	0.000754	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.000402	0.000748	CbGpPWpGaD
Quazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000401	0.000746	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000401	0.000746	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.0004	0.000743	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000398	0.000741	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000395	0.000735	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000395	0.000734	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000392	0.00073	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000392	0.000729	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000385	0.000715	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000381	0.000708	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000379	0.000706	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000379	0.000705	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000378	0.000703	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000376	0.0007	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000376	0.000699	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000372	0.000692	CbGpPWpGaD
Quazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000367	0.000683	CbGpPWpGaD
Quazepam—Diazepam—ABCB1—Parkinson's disease	0.000364	0.06	CrCbGaD
Quazepam—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000357	0.000664	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000356	0.000662	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000354	0.000659	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000352	0.000655	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000349	0.000649	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000348	0.000647	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000348	0.000647	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000346	0.000643	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000343	0.000638	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000342	0.000636	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000342	0.000636	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—COMT—Parkinson's disease	0.00034	0.000632	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.00034	0.000632	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000337	0.000628	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000336	0.000624	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000335	0.000623	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000334	0.000621	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000333	0.000619	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000331	0.000616	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00033	0.000613	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00033	0.000613	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000328	0.000609	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000322	0.000598	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000319	0.000594	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000314	0.000585	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000309	0.000574	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000303	0.000565	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000301	0.000561	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000301	0.000561	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000296	0.000551	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000292	0.000542	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000291	0.000542	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000291	0.000542	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.00029	0.000539	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000287	0.000534	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000281	0.000523	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000279	0.00052	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000278	0.000517	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000276	0.000513	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000274	0.00051	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00027	0.000502	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000267	0.000496	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000266	0.000495	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000265	0.000494	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000264	0.000492	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000263	0.000489	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000263	0.000489	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000262	0.000487	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000261	0.000485	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000259	0.000482	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000259	0.000481	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000254	0.000472	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000248	0.000461	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000243	0.000453	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000243	0.000452	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000239	0.000445	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000236	0.000438	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000229	0.000425	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000225	0.000419	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000224	0.000417	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000223	0.000414	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000222	0.000413	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000222	0.000413	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000221	0.00041	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00022	0.000409	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.00022	0.000409	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00022	0.000408	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000219	0.000408	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000218	0.000405	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000217	0.000403	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000216	0.000402	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000216	0.000402	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000215	0.0004	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000215	0.0004	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000211	0.000393	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000211	0.000392	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000208	0.000386	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000206	0.000384	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000203	0.000377	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000202	0.000375	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000201	0.000374	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.0002	0.000373	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.0002	0.000372	CbGpPWpGaD
Quazepam—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000199	0.00037	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000198	0.000369	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000197	0.000367	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000187	0.000348	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000184	0.000343	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000184	0.000342	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000184	0.000342	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000181	0.000338	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00018	0.000336	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000179	0.000334	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000179	0.000334	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000177	0.000329	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000176	0.000328	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000176	0.000328	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000175	0.000326	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000173	0.000322	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000173	0.000321	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000172	0.00032	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000169	0.000314	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000162	0.000301	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00016	0.000298	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000158	0.000294	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000154	0.000286	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000152	0.000283	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000148	0.000275	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000143	0.000266	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000143	0.000266	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000139	0.000258	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000135	0.00025	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000135	0.00025	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000133	0.000247	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000132	0.000246	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000132	0.000245	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000131	0.000243	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ND3—Parkinson's disease	0.00013	0.000243	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.00013	0.000243	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00013	0.000243	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00013	0.000242	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000128	0.000237	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000123	0.000228	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000123	0.000228	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000122	0.000226	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000121	0.000226	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00012	0.000223	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000116	0.000216	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000111	0.000206	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00011	0.000204	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000108	0.000202	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000108	0.000202	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000108	0.000202	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.0001	0.000186	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FBP1—Parkinson's disease	9.89e-05	0.000184	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GBA—Parkinson's disease	9.89e-05	0.000184	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DBH—Parkinson's disease	9.89e-05	0.000184	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ND3—Parkinson's disease	8.6e-05	0.00016	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	8.6e-05	0.00016	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	8.09e-05	0.00015	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—OMD—Parkinson's disease	8.09e-05	0.00015	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—DDC—Parkinson's disease	7.96e-05	0.000148	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	7.67e-05	0.000143	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTA4—Parkinson's disease	7.52e-05	0.00014	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	7.42e-05	0.000138	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GCH1—Parkinson's disease	7.32e-05	0.000136	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—DDC—Parkinson's disease	7.26e-05	0.000135	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTA4—Parkinson's disease	6.85e-05	0.000127	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	6.77e-05	0.000126	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.77e-05	0.000126	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MAOB—Parkinson's disease	6.7e-05	0.000125	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GBA—Parkinson's disease	6.52e-05	0.000121	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FBP1—Parkinson's disease	6.52e-05	0.000121	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DBH—Parkinson's disease	6.52e-05	0.000121	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	6.38e-05	0.000119	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	6.17e-05	0.000115	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MAOB—Parkinson's disease	6.11e-05	0.000114	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.81e-05	0.000108	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	4.98e-05	9.26e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CTGF—Parkinson's disease	4.89e-05	9.09e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—DDC—Parkinson's disease	4.79e-05	8.9e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	4.55e-05	8.47e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	4.54e-05	8.45e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.52e-05	8.41e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NQO1—Parkinson's disease	4.5e-05	8.38e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CTGF—Parkinson's disease	4.46e-05	8.29e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—TH—Parkinson's disease	4.44e-05	8.26e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYCS—Parkinson's disease	4.26e-05	7.93e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	4.15e-05	7.72e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NQO1—Parkinson's disease	4.11e-05	7.64e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.07e-05	7.57e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—TH—Parkinson's disease	4.05e-05	7.53e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.03e-05	7.49e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYCS—Parkinson's disease	3.88e-05	7.23e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—COMT—Parkinson's disease	3.77e-05	7.02e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTP1—Parkinson's disease	3.76e-05	6.99e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MAOA—Parkinson's disease	3.75e-05	6.97e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMOX1—Parkinson's disease	3.7e-05	6.89e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCB1—Parkinson's disease	3.55e-05	6.61e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTM1—Parkinson's disease	3.45e-05	6.42e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—COMT—Parkinson's disease	3.44e-05	6.4e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTP1—Parkinson's disease	3.42e-05	6.37e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MAOA—Parkinson's disease	3.42e-05	6.36e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMOX1—Parkinson's disease	3.38e-05	6.28e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GPX1—Parkinson's disease	3.3e-05	6.15e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCB1—Parkinson's disease	3.24e-05	6.03e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTM1—Parkinson's disease	3.15e-05	5.85e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.05e-05	5.67e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GPX1—Parkinson's disease	3.01e-05	5.61e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.99e-05	5.57e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.94e-05	5.47e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOE—Parkinson's disease	2.84e-05	5.28e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTHFR—Parkinson's disease	2.78e-05	5.17e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.74e-05	5.09e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.71e-05	5.04e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—TH—Parkinson's disease	2.67e-05	4.96e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOE—Parkinson's disease	2.59e-05	4.82e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.56e-05	4.77e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—INS—Parkinson's disease	2.43e-05	4.51e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—COMT—Parkinson's disease	2.27e-05	4.22e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.26e-05	4.2e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.25e-05	4.19e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.23e-05	4.14e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—INS—Parkinson's disease	2.21e-05	4.11e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.14e-05	3.98e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.08e-05	3.86e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.99e-05	3.7e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.83e-05	3.41e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOE—Parkinson's disease	1.71e-05	3.18e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—INS—Parkinson's disease	1.46e-05	2.71e-05	CbGpPWpGaD
